Comparing new treatments for idiopathic pulmonary fibrosis--a network meta-analysis.
Authors
Loveman, EmmaCopley, Vicky R
Scott, David A
Colquitt, Jill L
Clegg, Andrew J
O'Reilly, Katherine M A
Affiliation
1Effective Evidence LLP/Southampton Health Technology Assessments Centre (SHTAC), University of Southampton, 1st Floor Epsilon House, Enterprise Road, Southampton SO16 7NS, UK. 2SHTAC, University of Southampton, 1st Floor Epsilon House, Enterprise Road, Southampton SO16 7NS, UK. 3ICON Health Economics, Seacourt Tower, West Way, Oxford OX2 0JJ, UK. 4Mater Misericordiae University Hospital, Dublin, Ireland.Issue Date
2015Local subject classification
LUNG DISEASEPULMONARY FIBROSIS
Metadata
Show full item recordCitation
Comparing new treatments for idiopathic pulmonary fibrosis--a network meta-analysis. 2015, 15:37 BMC Pulm MedPublisher
BioMed CentralJournal
BMC pulmonary medicineDOI
10.1186/s12890-015-0034-yPubMed ID
25927225Abstract
The treatment landscape for idiopathic pulmonary fibrosis, a devastating lung disease, is changing. To investigate the effectiveness of treatments for idiopathic pulmonary fibrosis we undertook a systematic review, network meta-analysis and indirect comparison.Item Type
ArticleLanguage
enISSN
1471-2466Sponsors
Funder: This research was funded from internal funds from the Southampton Health Technology Assessments Centre (SHTAC) at the University of Southampton, UK. We are grateful to Karen Welch, Information Specialist, SHTAC, University of Southampton, for generating and running the literature searches.ae974a485f413a2113503eed53cd6c53
10.1186/s12890-015-0034-y
Scopus Count
Collections
Related articles
- Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis.
- Authors: Canestaro WJ, Forrester SH, Raghu G, Ho L, Devine BE
- Issue date: 2016 Mar
- Systematic Review and Network Meta-analysis of Idiopathic Pulmonary Fibrosis Treatments.
- Authors: Fleetwood K, McCool R, Glanville J, Edwards SC, Gsteiger S, Daigl M, Fisher M
- Issue date: 2017 Mar
- Treatment of idiopathic pulmonary fibrosis: a network meta-analysis.
- Authors: Rochwerg B, Neupane B, Zhang Y, Garcia CC, Raghu G, Richeldi L, Brozek J, Beyene J, Schünemann H
- Issue date: 2016 Feb 3
- A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK.
- Authors: Rinciog C, Watkins M, Chang S, Maher TM, LeReun C, Esser D, Diamantopoulos A
- Issue date: 2017 Apr
- Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
- Authors: Rogliani P, Calzetta L, Cavalli F, Matera MG, Cazzola M
- Issue date: 2016 Oct